| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-28 19:43:25 UTC |
|---|
| Updated at | 2022-04-28 19:43:25 UTC |
|---|
| NP-MRD ID | NP0074469 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Norisoboldine |
|---|
| Description | NORISOBOLDINE belongs to the class of organic compounds known as aporphines. These are quinoline alkaloids containing the dibenzo[de,g]quinoline ring system or a dehydrogenated derivative thereof. Norisoboldine is found in Beilschmiedia elliptica, Cassytha pubescens, Cocculus laurifolius, Croton lechleri, Croton lechleri Mull.Arg. , Fissistigma oldhamii, Guatteria dumetorum, Houttuynia cordata , Illigera pentaphylla, Litsea acuminata, Pachygone ovata, Monanthotaxis cauliflora, Stephania cephalantha and Zizyphus jujuba . Norisoboldine was first documented in 2018 (PMID: 30036998). Based on a literature review a significant number of articles have been published on NORISOBOLDINE (PMID: 35233835) (PMID: 34743982) (PMID: 34719823) (PMID: 34602563) (PMID: 34415684) (PMID: 33556569). |
|---|
| Structure | COC1=CC2=C(C[C@@H]3NCCC4=CC(OC)=C(O)C2=C34)C=C1O InChI=1S/C18H19NO4/c1-22-14-8-11-10(6-13(14)20)5-12-16-9(3-4-19-12)7-15(23-2)18(21)17(11)16/h6-8,12,19-21H,3-5H2,1-2H3/t12-/m0/s1 |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C18H19NO4 |
|---|
| Average Mass | 313.3530 Da |
|---|
| Monoisotopic Mass | 313.13141 Da |
|---|
| IUPAC Name | (9S)-4,15-dimethoxy-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2(7),3,5,13,15-hexaene-5,16-diol |
|---|
| Traditional Name | (9S)-4,15-dimethoxy-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2(7),3,5,13,15-hexaene-5,16-diol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC1=CC2=C(C[C@@H]3NCCC4=CC(OC)=C(O)C2=C34)C=C1O |
|---|
| InChI Identifier | InChI=1S/C18H19NO4/c1-22-14-8-11-10(6-13(14)20)5-12-16-9(3-4-19-12)7-15(23-2)18(21)17(11)16/h6-8,12,19-21H,3-5H2,1-2H3/t12-/m0/s1 |
|---|
| InChI Key | HORZNQYQXBFWNZ-LBPRGKRZSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as aporphines. These are quinoline alkaloids containing the dibenzo[de,g]quinoline ring system or a dehydrogenated derivative thereof. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Aporphines |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Aporphines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Aporphine
- Benzoquinoline
- Phenanthrene
- 1-naphthol
- Naphthalene
- Tetrahydroisoquinoline
- Quinoline
- Anisole
- Phenol ether
- Alkyl aryl ether
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Phenol
- Benzenoid
- Azacycle
- Secondary aliphatic amine
- Ether
- Organoheterocyclic compound
- Secondary amine
- Amine
- Organic nitrogen compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - He Y, Cheng P, Wang W, Yan S, Tang Q, Liu D, Xie H: Rapid Investigation and Screening of Bioactive Components in Simo Decoction via LC-Q-TOF-MS and UF-HPLC-MD Methods. Molecules. 2018 Jul 20;23(7). pii: molecules23071792. doi: 10.3390/molecules23071792. [PubMed:30036998 ]
- Zhang Q, Fang Y, Lv C, Zhu Y, Xia Y, Wei Z, Dai Y: Norisoboldine induces the development of Treg cells by promoting fatty acid oxidation-mediated H3K27 acetylation of Foxp3. FASEB J. 2022 Apr;36(4):e22230. doi: 10.1096/fj.202101643R. [PubMed:35233835 ]
- Fang Y, Duan C, Zhang J, Dai Y, Xia Y: NMR-based untargeted metabolomics approach to investigate the systemic lipid metabolism regulation of norisoboldine in collagen-induced arthritis rats. Eur J Pharmacol. 2021 Dec 5;912:174608. doi: 10.1016/j.ejphar.2021.174608. Epub 2021 Oct 28. [PubMed:34743982 ]
- Xing D, Li Q, Lin G, Lin H, Kang W, Zhang M, Ding R, Li N: The protective effects of propofol against renal ischemia-reperfusion injury are potentiated by norisoboldine treatment via inhibition of oxidative stress pathways. J Biochem Mol Toxicol. 2022 Jan;36(1):e22937. doi: 10.1002/jbt.22937. Epub 2021 Oct 31. [PubMed:34719823 ]
- Chen Q, Shao X, He Y, Lu E, Zhu L, Tang W: Norisoboldine Attenuates Sepsis-Induced Acute Lung Injury by Modulating Macrophage Polarization via PKM2/HIF-1alpha/PGC-1alpha Pathway. Biol Pharm Bull. 2021;44(10):1536-1547. doi: 10.1248/bpb.b21-00457. [PubMed:34602563 ]
- Wu X, Long H, Li F, Wu W, Zhou J, Liu C, Hou J, Wu W, Guo D: Comprehensive feature-based molecular networking and metabolomics approaches to reveal the differences components in Cinnamomum cassia and Cinnamomum verum. J Sep Sci. 2021 Oct;44(20):3810-3821. doi: 10.1002/jssc.202100399. Epub 2021 Sep 1. [PubMed:34415684 ]
- Chang L, Zhang Q, Tang Y, Fang Y, Dou R, Chu Y, Xia Y, Wei Z, Chen L, Dai Y: Synthesis of norisoboldine derivatives and bioactivity assay for inducing the generation of regulatory T cells. Bioorg Med Chem Lett. 2021 Apr 1;37:127844. doi: 10.1016/j.bmcl.2021.127844. Epub 2021 Feb 5. [PubMed:33556569 ]
- Zhang J, Wen X, Dai Y, Xia Y: Mechanistic studies on the absorption enhancement of a self-nanoemulsifying drug delivery system loaded with norisoboldine-phospholipid complex. Int J Nanomedicine. 2019 Sep 2;14:7095-7106. doi: 10.2147/IJN.S211905. eCollection 2019. [PubMed:31564867 ]
- Huang M, Su J, Lou Z, Xie F, Pan W, Yang Z, Gu L, Xie F, Xu Z, Zhang L, Liu F, Lai H, Zhang L, Lin N: Application of a DSS colitis model in toxicologically assessing norisoboldine. Toxicol Mech Methods. 2020 Feb;30(2):107-114. doi: 10.1080/15376516.2019.1669242. Epub 2019 Oct 2. [PubMed:31532267 ]
|
|---|